Review Article

A Systematic Review of Single Chinese Herbs for Alzheimer's Disease Treatment

Table 1

The study design, herbal intervention, outcome measures, and results of RCTs concerning single Chinese herbs in the treatment of AD.

StudyDesignHerb nameQualityRx NCx NOutcome measuresaSide effectsResults

Maurer et al. [14]Randomized, double-blind, placebo-controlled, parallelG. biloba (EGb761) 80 mg tid for 3 months31010SKTNo adverse events Placebo (SKT) ( )

Schneider et al. [15]Randomized, double-blind, placebo-controlled, parallel, multi-centerG. biloba (EGb761) 120 mg or 240 mg per day for 26 weeks4169 (120 mg) 170 (240 mg)174ADAS-cog, ADCS-CGICRelated serious adverse events (1% in 120 mg Gp and 2% in 240 mg Gp)   Placebo

Mazza et al. [16]Randomized, double-blind, placebo-controlled, parallelG. biloba (EGb761) 160 mg per day for 24 weeks52525b, 26cSKT MMSE CGINo adverse events(1)  Donepezil(2) Placebo (SKT, CGI) ( )(3) Placebo (MMSE)

Xu et al. [17]Randomized, double-blind, placebo-controlled, parallel, multi-centerHuperzine A 0.2 mg b.i.d. for 8 weeks35053Wechsler, Hasegawa, MMSENo severe side effects Placebo ( )

Zhang et al. [18]Randomized, double-blind, placebo-controlled, parallel, multi-centerHuperzine A 0.4 mg per day for 12 weeks4100102ADAS MMSEAnkle edema, insomnia (3%) Placebo ( )

Heo et al. [19]Randomized, non-blinding, controlled, parallelGinseng 4.5 g or 9.0 g per day for 12 weeks115 (9 g)15 (4.5 g), 31ADAS, MMSE, CDRNausea, fever (13%)(1) Rx (9 g) Cx (ADAS-cog, CDR) ( )(2) (MMSE)

Rx, Herbal treatment; Cx: Control intervention. Rx     Cx: The treatment is more effective than the control intervention. Rx     Cx: No statistically significant difference between the treatment and control interventions.
aPrimary outcome measure; bDonepezil 5 mg per day; cPlacebo.